We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tyson Foods (TSN) Gains on High Retail Demand, Cost Woes Stay
Read MoreHide Full Article
Tyson Foods, Inc. (TSN - Free Report) is in a good shape, with its retail business thriving on elevated at-home consumption amid the pandemic. Further, rising demand for protein-packed products has been aiding Tyson Foods, which remains focused on enhancing its brand portfolio to keep pace with consumers’ interests. However, the company has been battling hurdles in its foodservice business due to the pandemic-led social distancing. Also, costs associated with COVID-19 have been concerning.
Retail Strength & Rising Demand for Protein
Tyson Foods has been benefiting from increasing demand in its retail channel, thanks to higher at-home consumption amid the pandemic. In the fourth quarter of fiscal 2020, the company’s retail core business lines saw share growth for the ninth consecutive time. Core retail line volumes rose about 15% in the last 13 weeks, per management’s conference call on Nov 16. In fact, given the rising demand, the company has also shifted part of its foodservice production to concentrate on retail. Management expects to see elevated at-home dining in fiscal 2021, which is likely to aid retail volumes. Another channel performing well for Tyson Foods is e-commerce, which saw its sales more than double in the fourth quarter and surge 99% in fiscal 2020 as more consumers are buying online amid the pandemic. Management expects continued strength in the e-commerce channel.
Apart from these, Tyson Foods remains focused on increasing protein production to cater to the rising demand for protein-packed food. For fiscal 2021, USDA expects overall domestic protein production (chicken, beef, pork and turkey) to rise about 1% year over year. In the Beef segment, USDA projects domestic production to grow about 2% in fiscal 2021. In the Prepared Foods segment, the company focuses on responding to the changing consumer behavior as it goes into fiscal 2021. Finally, the company anticipates better results from its operations in the International/Other segment. Though management projects food and protein demand to shift among different sales networks and witness short-term hiccups amid the pandemic, worldwide demand is expected to increase over time. Notably, management anticipates sales to be $42-$44 billion in fiscal 2021.
Will Hurdles be Countered?
While Tyson Foods is benefiting from rising retail demand, foodservice demand continues being affected by below-normal operations at schools and cafeterias. These factors, along with increased staff absenteeism amid the pandemic, have been elevating costs and complexities regarding the company’s operations in the United States as well as Europe. The company expects to continue facing pandemic-related hurdles in the first half of fiscal 2021.
Besides, high costs have been concerning Tyson Foods, which incurred $200 million as direct incremental expenses associated with COVID-19 in the fourth quarter. Incremental COVID-19 costs amounted to $540 million for fiscal 2020. These include escalated costs related to workers’ health and production facility downtimes, such as personal protection equipment, sanitization of production facilities, testing for coronavirus and product downgrades, among others. Apart from these, certain indirect COVID-19 costs like raw materials, transportation, underutilization and reconfiguration of plant, premiums offered to cattle producers and discounts on pricing dented results. Management expects COVID-19 costs worth roughly $330 million in fiscal 2021.
That being said, this Zacks Rank #3 (Hold) company has been committed to several operational and supply-chain efficiency programs to place itself better for the long run. Also, the company is constantly looking for ways to improve cost structure, alongside achieving operational improvements and providing better customer service. These upsides, together with Tyson Foods’ robust brand presence, geographical reach and solid retail business, bode well.
Shares of this renowned meat products company have rallied 10.4% in the past three months against the industry’s decline of 1.1%.
Nomad Foods (NOMD - Free Report) has a Zacks Rank #2 (Buy) and a trailing four-quarter earnings surprise of 10.2%, on average.
Hain Celestial (HAIN - Free Report) has a Zacks Rank #2 and a trailing four-quarter earnings surprise of 24.6%, on average.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Shutterstock
Tyson Foods (TSN) Gains on High Retail Demand, Cost Woes Stay
Tyson Foods, Inc. (TSN - Free Report) is in a good shape, with its retail business thriving on elevated at-home consumption amid the pandemic. Further, rising demand for protein-packed products has been aiding Tyson Foods, which remains focused on enhancing its brand portfolio to keep pace with consumers’ interests. However, the company has been battling hurdles in its foodservice business due to the pandemic-led social distancing. Also, costs associated with COVID-19 have been concerning.
Retail Strength & Rising Demand for Protein
Tyson Foods has been benefiting from increasing demand in its retail channel, thanks to higher at-home consumption amid the pandemic. In the fourth quarter of fiscal 2020, the company’s retail core business lines saw share growth for the ninth consecutive time. Core retail line volumes rose about 15% in the last 13 weeks, per management’s conference call on Nov 16. In fact, given the rising demand, the company has also shifted part of its foodservice production to concentrate on retail. Management expects to see elevated at-home dining in fiscal 2021, which is likely to aid retail volumes. Another channel performing well for Tyson Foods is e-commerce, which saw its sales more than double in the fourth quarter and surge 99% in fiscal 2020 as more consumers are buying online amid the pandemic. Management expects continued strength in the e-commerce channel.
Apart from these, Tyson Foods remains focused on increasing protein production to cater to the rising demand for protein-packed food. For fiscal 2021, USDA expects overall domestic protein production (chicken, beef, pork and turkey) to rise about 1% year over year. In the Beef segment, USDA projects domestic production to grow about 2% in fiscal 2021. In the Prepared Foods segment, the company focuses on responding to the changing consumer behavior as it goes into fiscal 2021. Finally, the company anticipates better results from its operations in the International/Other segment. Though management projects food and protein demand to shift among different sales networks and witness short-term hiccups amid the pandemic, worldwide demand is expected to increase over time. Notably, management anticipates sales to be $42-$44 billion in fiscal 2021.
Will Hurdles be Countered?
While Tyson Foods is benefiting from rising retail demand, foodservice demand continues being affected by below-normal operations at schools and cafeterias. These factors, along with increased staff absenteeism amid the pandemic, have been elevating costs and complexities regarding the company’s operations in the United States as well as Europe. The company expects to continue facing pandemic-related hurdles in the first half of fiscal 2021.
Besides, high costs have been concerning Tyson Foods, which incurred $200 million as direct incremental expenses associated with COVID-19 in the fourth quarter. Incremental COVID-19 costs amounted to $540 million for fiscal 2020. These include escalated costs related to workers’ health and production facility downtimes, such as personal protection equipment, sanitization of production facilities, testing for coronavirus and product downgrades, among others. Apart from these, certain indirect COVID-19 costs like raw materials, transportation, underutilization and reconfiguration of plant, premiums offered to cattle producers and discounts on pricing dented results. Management expects COVID-19 costs worth roughly $330 million in fiscal 2021.
That being said, this Zacks Rank #3 (Hold) company has been committed to several operational and supply-chain efficiency programs to place itself better for the long run. Also, the company is constantly looking for ways to improve cost structure, alongside achieving operational improvements and providing better customer service. These upsides, together with Tyson Foods’ robust brand presence, geographical reach and solid retail business, bode well.
Shares of this renowned meat products company have rallied 10.4% in the past three months against the industry’s decline of 1.1%.
3 Solid Consumer Staple Stocks
B&G Foods (BGS - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy), has a trailing four-quarter earnings surprise of 9.3%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
Nomad Foods (NOMD - Free Report) has a Zacks Rank #2 (Buy) and a trailing four-quarter earnings surprise of 10.2%, on average.
Hain Celestial (HAIN - Free Report) has a Zacks Rank #2 and a trailing four-quarter earnings surprise of 24.6%, on average.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>